acneform


Also found in: Dictionary.

ac·ne·form

(ak'nē-fōrm),
Resembling acne.
Synonym(s): acneiform

acneform

[ak′nifôrm]
resembling acne. Also acneiform [aknē′əfôrm] .

ac·ne·form

, acneiform (ak'nē-fōrm, ak-nē'i-fōrm)
Resembling acne.

acneiform

, acneform (ak-nē′ĭ-form″) (ak-nē′form″) [ acne + -form]
Resembling acne.
References in periodicals archive ?
The most frequent adverse events seen in patients with carcinomas of the head and neck receiving ERBITUX in combination with radiation therapy (n=208) versus radiation alone (n=212) (incidence greater than or equal to 50%) were acneform rash (87%/10%), radiation dermatitis (86%/90%), weight loss (84%/72%), and asthenia (56%/49%).
The most frequent adverse events seen in patients with metastatic colorectal cancer (n=354) treated with ERBITUX plus irinotecan in clinical trials (incidence greater than or equal to 50%) were acneform rash (88%), asthenia/malaise (73%), diarrhea (72%), and nausea (55%).
a[yen]10%) included: radiation dermatitis (23%), acneform rash (17%),
trials (incidence eN50%) were acneform rash (88%), asthenia/malaise (73%),
In clinical studies of ERBITUX, dermatologic toxicities, including acneform rash, skin drying and fissuring, inflammatory and infectious sequelae (eg, blepharitis, cheilitis, cellulitis, cyst), and hypertrichosis were reported.
In clinical studies of ERBITUX, dermatologic toxicities, including acneform rash, skin drying and fissuring, and inflammatory and infectious sequelae (eg, blepharitis, cheilitis, cellulitis, cyst) were reported.
The most frequent adverse events seen in patients with carcinomas of the head and neck receiving ERBITUX in combination with radiation therapy (n=208) versus radiation alone (n=212) (incidence =50%) were acneform rash (87%/10%), radiation dermatitis (86%/90%), weight loss (84%/72%), and asthenia (56%/49%).
The most frequent adverse events seen in patients with carcinomas of the head and neck receiving ERBITUX in combination with radiation therapy (n=208) versus radiation alone (n=212) (incidence [greater than or equal to]50%) were acneform rash (87%/10%), radiation dermatitis (86%/90%), weight loss (84%/72%), and asthenia (56%/49%).
The most frequent adverse events seen in patients with metastatic colorectal cancer (n=354) treated with ERBITUX plus irinotecan in clinical trials (incidence [greater than or equal to]50%) were acneform rash (88%), asthenia/malaise (73%), diarrhea (72%), and nausea (55%).
Dermatologic toxicities, including acneform rash (11% of 774 patients, grade 3/4), skin drying and fissuring, inflammatory or infectious sequelae (e.
For example, many patients treated with EGFR inhibitors develop dermatological toxicity, including skin drying, fissuring, and acneform rash that may cause the reduction, interruption or discontinuation of treatment.
Dermatologic toxicities, including acneform rash (12% grade 3-4), skin drying and fissuring, and inflammatory or infectious sequelae (e.